(Press-News.org) By including chemotherapy as a conditioning regimen prior to treatment, researchers have developed a refined gene therapy approach that safely and effectively restores the immune system of children with a form of severe combined immunodeficiency (SCID), according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
SCID is a group of rare and debilitating genetic disorders that affect the normal development of the immune system in newborns. Infants with SCID are prone to serious, life-threatening infections within the first few months of life and require extensive treatment for survival beyond infancy.
Adenosine deaminase (ADA) deficiency, which accounts for approximately 15 percent of all SCID cases, develops when a gene mutation prohibits the production of ADA, an enzyme that breaks down toxic molecules that can accumulate to harmful levels and kill lymphocytes, the specialized white blood cells that help make up the immune system. In its absence, infants with ADA-deficient SCID lack almost all immune defenses and their condition is almost always fatal within two years if left untreated. Standard treatment for ADA-deficient SCID is a hematopoietic stem cell transplant (HSCT) from a sibling or related donor; however, finding a matched donor can be difficult and transplants can carry significant risks. An alternate treatment method, enzyme replacement therapy (ERT), involves regular injections of the ADA enzyme to maintain the immune system and can help restore immune function; however, the treatments are extremely expensive and painful for the young patients and the effects are often only temporary.
Given the limitations of HSCT and ERT, in the 1990s researchers began investigating the efficacy of gene therapy for ADA-deficient SCID. They discovered that they could "correct" the function of a mutated gene by adding a healthy copy into the cells of the body that help fight infectious diseases. Since then, there have been significant advances in gene therapy for SCID, yet successful gene therapy in patients with ADA-deficient SCID has been seen in only a small series of children due to the difficulty of introducing a healthy ADA gene into bone marrow stem cells and to engraft these cells back into the patients.
"Although the basic steps of gene therapy for patients with SCID have been known for a while, technical and clinical challenges still exist and we wanted to find an optimized gene therapy protocol to restore immunity for young children with ADA-deficient SCID," said Fabio Candotti, MD, one of the study's senior authors, senior investigator in the Genetics and Molecular Biology Branch of the National Human Genome Research Institute at the National Institutes of Health, and chair of the ASH Scientific Committee on Immunology and Host Defense.
To determine whether an enhanced gene therapy approach would improve immunity in children with ADA-deficient SCID, the teams of Dr. Candotti and Donald B. Kohn, MD, director of the Human Gene Medicine Program at the University of California, Los Angeles (UCLA), Professor of Pediatrics and of Microbiology, Immunology, and Molecular Genetics, and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, conducted a clinical trial in 10 patients with the disorder. For the first time, Drs. Candotti and Kohn and their team of investigators compared two different retroviral vectors, MND-ADA and GCsapM-ADA, to transport normal ADA genes into the young patients' bone marrow stem cells as well as two different treatment plans in preparation for receiving gene therapy. Following therapy, investigators found that more bone marrow stem cells were marked with the MND-ADA vector, demonstrating its superiority over the GCsapM-ADA vector.
The investigators also sought to determine whether providing a low dose of chemotherapy prior to gene therapy, known as a pre-transplant conditioning regimen, would successfully deplete the young patients' bone marrow stem cells and make room for gene-corrected stem cells. In four patients, gene therapy was performed without chemotherapy, and the patients remained on ERT throughout the entire procedure to evaluate the efficiency of ERT combined with gene therapy. While these patients did not experience any adverse effects, they also did not experience a significant increase in their levels of the ADA enzyme. They also maintained low absolute lymphocyte counts (ALC) and minimal immune system function, leading the researchers to believe that ERT may weaken the therapy's effect by diluting the number of gene-corrected lymphocytes.
The remaining six patients were treated with the chemotherapy drug busulfan prior to gene therapy and ERT was discontinued prior to the gene therapy procedure. A significant increase in ADA was observed in all six patients; half of them remain off of ERT with partial immune reconstitution – findings that support results from prior trials in Italy and the United Kingdom using chemotherapy prior to gene therapy and discontinuting ERT. While the ALC of all six patients declined sharply in the first few months due to combined effects of busulfan administration and ERT withdrawal, their counts increased from six to 24 months, even in the three patients that remained off of ERT. After adjusting the chemotherapy dosage, investigators were able to determine an optimal level for enhancing the efficacy of the gene-therapy-corrected cells with minimal toxicity.
This study is the first to detail comparisons of ADA-deficient SCID patient outcomes between those treated with gene therapy who have not received pre-transplant conditioning while continuing to receive ERT with those receiving pre-transplant conditioning without the administration of ERT. This study is also the first to compare two different viral vectors to transport normal ADA genes into patient bone marrow.
"We were very happy that in this trial we were able to see a benefit in the patients after we modified the protocol," said Dr. Kohn. "Doctors treating ADA-deficient SCID have had too few options for too long, and we hope this will provide them with an efficient and effective treatment for this devastating disease."
###
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
Researchers improve gene therapy technique for children with immune disorder
2012-09-11
ELSE PRESS RELEASES FROM THIS DATE:
What do saving money and losing weight have in common?
2012-09-11
Consumers will pay more when they are given different options to pursue short-term goals, but will pay more for similar options when pursuing long-term goals, according to a new study in the Journal of Consumer Research.
"Many of the benefits of pursuing self-control goals such as being healthy are experienced in the future. Thus, a key component of our success in meeting our goals is the ability to remain motivated. One way for consumers to manage motivation is to strategically choose the options available to them in pursuing their goals," write authors Jordan Etkin ...
Parents of babies with sickle cell trait are less likely to receive genetic counseling, study says
2012-09-11
Ann Arbor, Mich. — Parents of newborns with the sickle cell anemia trait were less likely to receive genetic counseling than parents whose babies are cystic fibrosis carriers, a new study from the University of Michigan shows.
University of Michigan researchers found that 20 percent of physicians reported their patients with newborns carrying the sickle cell trait did not get any genetic counseling. In contrast, parents of babies who were cystic fibrosis carriers received more counseling overall (92 percent vs. 80 percent).
The research was published online in the ...
Report recommends cost-effective plan to strengthen US defense against ballistic missile attacks
2012-09-11
WASHINGTON ― To more effectively defend against ballistic missile attacks, the U.S. should concentrate on defense systems that intercept enemy missiles in midcourse and stop spending money on boost-phase defense systems of any kind, concludes a new, congressionally mandated report from a committee of the National Research Council.
The committee was asked to assess the feasibility, practicality, and affordability of U.S. boost-phase missile defenses and compare them with other alternatives for countering limited nuclear or conventional ballistic missile attacks ...
At least 200,000 tons of oil and gas from Deepwater Horizon spill consumed by gulf bacteria
2012-09-11
Researchers from the University of Rochester and Texas A&M University have found that, over a period of five months following the disastrous 2010 Deepwater Horizon explosion and oil spill, naturally-occurring bacteria that exist in the Gulf of Mexico consumed and removed at least 200,000 tons of oil and natural gas that spewed into the deep Gulf from the ruptured well head.
The researchers analyzed an extensive data set to determine not only how much oil and gas was eaten by bacteria, but also how the characteristics of this feast changed with time.
"A significant amount ...
Trouble in paradise: Does nature worship harm the environment?
2012-09-11
Consumers nurture romantic ideas of nature by engaging in practices that are often harmful to the environment, according to a new study in the Journal of Consumer Research. Could eco-friendly products provide a solution?
"Nature is often considered the ideal place to escape from everyday life. Consumers enjoy romantic escapes from culture in contexts as diverse as surfing, tropical island holidays, and the Burning Man festival. But by viewing nature as simply the opposite of culture, consumers often expedite the destruction of the experiences of nature they desire most," ...
Eat dessert first? It might help you control your diet
2012-09-11
Consumers watching their diet should pay close attention to the amount of unhealthy foods they eat, but can relax when it comes to healthier options, according to a new study in the Journal of Consumer Research.
"Although self-control is typically viewed as a battle between willpower and desire, consumers can't rely entirely on willpower to control their eating. They also need to create situations that will make them lose interest in food. One way is to keep better track of the quantity of unhealthy foods they eat," write authors Joseph P. Redden (University of Minnesota) ...
Want to encourage eco-friendly behavior? Give consumers a nudge (Don't tell them what to do)
2012-09-11
Consumers are more likely to change their behavior if they voluntarily commit to changing rather than being told what to do, according to a new study in the Journal of Consumer Research. So carefully nudge them along if you're trying to encourage more eco-friendly behavior.
"Commitment promotes consistent changes in behavior, especially if consumers pledge specific steps to promote the desired behavior. Consumers who publicly express a commitment to the environment will reinforce their commitment and increase sustainable behavior," write authors Katie Baca-Motes, Amber ...
Under the influence: Reminders of money impact consumer decision-making
2012-09-11
When reminded of money (not cost), consumers are more likely to evaluate a new product based on its primary features or brand name, according to a new study in the Journal of Consumer Research.
"Money and symbols of money are ubiquitous in our daily consumer environment, and money is linked to social resources such as security, status, power, confidence, and freedom. Mere reminders of money have the potential to signal confidence and strength and thereby impact consumers when making decisions," write authors Jochim Hansen (University of Salzburg), Florian Kutzner (University ...
Molecular beacons light up stem cell transformation
2012-09-11
PROVIDENCE, R.I. [Brown University] — A novel set of custom-designed "molecular beacons" allows scientists to monitor gene expression in living populations of stem cells as they turn into a specific tissue in real-time. The technology, which Brown University researchers describe in a new study, provides tissue engineers with a potentially powerful tool to discover what it may take to make stem cells transform into desired tissue cells more often and more quickly. That's a key goal in improving regenerative medicine treatments.
"We're not the inventors of molecular beacons ...
How genetics shape our addictions
2012-09-11
This press release is available in French. Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism. Previous research shows that greater reactivity to smoking cues predicts decreased success at smoking cessation ...